ECX.F Epigenomics AG up 14.29% to €1.20 on XETRA intraday: liquidity focus
ECX.F stock jumps 14.29% to €1.20 intraday on XETRA; liquidity and Meyka AI forecast in focus.
ECX.F stock jumps 14.29% to €1.20 intraday on XETRA; liquidity and Meyka AI forecast in focus.
Flock Safety cameras face growing pushback in U.S. cities as Lynnwood, WA cancels its ALPR deal. We assess privacy risks, vandalism, regulation, and what investors in govtech should watch now.
ENT.AX stock rose 25.00% to A$0.005 at ASX close 25 Feb 2026. Low volume and Meyka AI forecast show modest near-term upside.
Trump 401k plan from the State of the Union could boost stock market flows into low‑cost index funds, supporting ^GSPC, while tariff policy risk on a 10% base rate clouds margins. Singapore investors:
MOTE stock trades at $28.78 pre-market; short-term oversold bounce setup and Meyka AI forecast project upside
Oppenheimer maintained Outperform on Oppenheimer Holdings Inc. OPY analyst rating held on Feb 24, 2026
AKI.NS stock fell 18.36% after hours to INR 4.98 on 25 Feb 2026; read analysis, grade and forecasts
Intraday volume spike for MA13.PA stock on EURONEXT; liquidity and NAV moves suggest trading signal
Claude Code and new Anthropic Claude plugins tied to Microsoft Excel integration lifted software stocks and buoyed the Nasdaq-100. What Singapore investors should watch now.
Intraday volume spike lifts SCR.SW stock to CHF25.90; high relative volume ahead of earnings on 04 Mar 2026